Literature DB >> 9833949

Mapping of the human insulin receptor substrate-2 gene, identification of a linked polymorphic marker and linkage analysis in families with Type II diabetes: no evidence for a major susceptibility role.

K Kalidas1, J Wasson, B Glaser, J M Meyer, L J Duprat, M F White, M A Permutt.   

Abstract

Insulin receptor substrate 2 (IRS-2) is a substrate of the insulin receptor and mediates the action of the insulin. Disruption of the IRS-2 gene in mice results in peripheral insulin resistance and relative insulin deficiency. It is therefore possible that defects in the IRS-2 gene contribute to Type II (non-insulin-dependent) diabetes mellitus. We have examined the gene for evidence of linkage to Type II diabetes in Ashkenazi Jewish families. Radiation hybrid panel mapping was used to refine the map position of the IRS-2 gene and, in the absence of polymorphic markers within the gene, to identify nearby markers. The IRS-2 gene was placed 23cR from the marker D13S1265 on chromosome 13q34. 200 affected sib-pairs were genotyped for three markers across the region. Nonparametric linkage analysis (GENEHUNTER) used with this data found no evidence of excess allele sharing in the IRS-2 gene region. We therefore concluded that variation in the IRS-2 gene is unlikely to contribute to Type II diabetes in this discrete Caucasian population.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9833949     DOI: 10.1007/s001250051081

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  8 in total

Review 1.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Authors:  A Virkamäki; K Ueki; C R Kahn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

2.  Pdx1 restores beta cell function in Irs2 knockout mice.

Authors:  Jake A Kushner; Jing Ye; Markus Schubert; Deborah J Burks; Matthew A Dow; Carrie L Flint; Sanjoy Dutta; Christopher V E Wright; Marc R Montminy; Morris F White
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

3.  Complex haplotypes of IRS2 gene are associated with severe obesity and reveal heterogeneity in the effect of Gly1057Asp mutation.

Authors:  Corinne Lautier; Samira Ait El Mkadem; Eric Renard; Jean Frédéric Brun; Jean Christophe Gris; Jacques Bringer; Florin Grigorescu
Journal:  Hum Genet       Date:  2003-04-10       Impact factor: 4.132

Review 4.  Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review.

Authors:  Bhaskar Venkata Kameswara Subrahmanya Lakkakula; Maheswari Thangavelu; Usha Rani Godla
Journal:  J Assist Reprod Genet       Date:  2013-06-22       Impact factor: 3.412

5.  Resequencing of IRS2 reveals rare variants for obesity but not fasting glucose homeostasis in Hispanic children.

Authors:  Nancy F Butte; V Saroja Voruganti; Shelley A Cole; Karin Haack; Anthony G Comuzzie; Donna M Muzny; David A Wheeler; Kyle Chang; Alicia Hawes; Richard A Gibbs
Journal:  Physiol Genomics       Date:  2011-07-19       Impact factor: 3.107

6.  Insulin receptor substrate-2 is expressed in kidney epithelium and up-regulated in diabetic nephropathy.

Authors:  Michelle B Hookham; Helen C O'Donovan; Rachel H Church; Annie Mercier-Zuber; Lucilla Luzi; Simon P Curran; Rosemarie M Carew; Alejandra Droguett; Sergio Mezzano; Markus Schubert; Morris F White; John K Crean; Derek P Brazil
Journal:  FEBS J       Date:  2013-05-29       Impact factor: 5.542

7.  Structural equation model-based genome scan for the metabolic syndrome.

Authors:  Catherine M Stein; Yeunjoo Song; Robert C Elston; Gyungah Jun; Hemant K Tiwari; Sudha K Iyengar
Journal:  BMC Genet       Date:  2003-12-31       Impact factor: 2.797

8.  Systems Biology Approaches and Applications in Obesity, Diabetes, and Cardiovascular Diseases.

Authors:  Qingying Meng; Ville-Petteri Mäkinen; Helen Luk; Xia Yang
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-10-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.